OPINION of ANSES on the “Request concerning extension of the list of substances with additional clinical benefit to other substances of interest in equine medicine”
Opinion and Report of Anses relating to the effectiveness of consumer information and prevention of microbiological risks in food – Volume 2 : assessing the effectiveness of communication strategies
OPINION of ANSES on the application for authorisation to use 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctanesulphonic acid (CAS No. 27619-97-2) and its potassium salt (CAS No.59587-38-1) in the manufacture of organic materials coming into contact with drinking water
Opinion of ANSES on a draft decree pursuant to Article L. 214-1 of the French Consumer Code and concerning the labelling of raw milk intended to be provided for direct consumption by the final consumer